Clopidogrel thiolactone onine-(S R)-sulfoximine hydrochloride Zoledronic acid affects breast cancer

Zoledronic acid affects breast cancer metastasis to visceral organs as well as bone

a dual specificity threonine/tyrosine kinase

for 21 days) treatment clearly protects from lethal nasal exposure to ricin in mice

Smiles: C[C@@]12O[C@H]1[C@H](C)[C@@H]1C[C@@](O)(NC(=O)O1)[C@@H](C=CC=C(C)CC1=CC(=C(Cl)C(=C1)OC)N(C)C(=O)C[C@@H]2OC(=O)[C@H](C)NC)OC |c:19

CAS Number: 93076-89-2

Clopidogrel thiolactone onine-(S R)-sulfoximine hydrochloride Zoledronic acid affects breast cancerClopidogrel thiolactone is a P2Y12 receptor inhibitor, is a potent antiplatelet agent. Target: P2Y12Clopidogrel thiolactone is the metabolic intermediate resulting from the first oxidative activation of clopidogrel. Product information CAS Number: 1147350 75 1 Molecular Weight: 337. 82 Formula: C16H16ClNO3S Chemical Name: methyl (2S) 2 (2 chlorophenyl) 2 {2 oxo 2H,4H,5H,6H,7H,7aH thieno[3,2 c]pyridin 5 yl}acetate Smiles: